John Lunger
Corporate Officer/Principal at ADAPTIMMUNE THERAPEUTICS PLC
Net worth: 227 614 $ as of 2024-03-30
Profile
John Lunger is currently the Chief Patient Supply Officer at Adaptimmune Therapeutics Plc.
He previously worked as an Independent Director at Genocea Biosciences, Inc. and as the Head-Supply Chain & Commercial Product Supply at Merrimack Pharmaceuticals, Inc. Mr. Lunger completed his undergraduate degree at the United States Naval Academy and holds an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 816,936 ( 0.14% ) | 215 173 $ | 2024-03-30 | |
| 2024-01-11 | 7,874 ( 0.00% ) | 12 441 $ | 2024-03-30 |
John Lunger active positions
| Companies | Position | Start |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 2017-02-28 |
Former positions of John Lunger
| Companies | Position | End |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| GENOCEA BIOSCIENCES, INC. | Director/Board Member | - |
Training of John Lunger
| United States Naval Academy | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
- Stock Market
- Insiders
- John Lunger